FDA approves Abbott's Humira for ulcerative colitis The FDA said it expanded the approved use of Humira to include treatment of moderate-to-severe ulcerative colitis in adults. Humira is approved to control ulcerative colitis when immunosuppressant medicines like corticosteroids, azathioprine, and 6-mercaptopurine have not worked. Humira is manufactured by Abbott Laboratories.
News For ABT From The Last 14 Days
Check below for free stories on ABT the last two weeks.
UBS to host a conference Global Healthcare Services Conference is being held in New York on May 20-22 with webcasted company presentations to begin on May 22 at 8 am; not all company presentations may be webcasted. Webcast Link
Abbott upgraded to Buy from Neutral at Goldman Goldman upgraded Abbott to reflect accelerating growth driven by emerging markets, better growth and product mix, new product launches, and market share gains. Price target raised to $44 from $38.
Subscribe for More Information